In recent years, bio-medical engineers have been developing promising techniques that could help diagnose diseases or ...

Nanoparticle formulation has emerged as a pivotal innovation in the field of drug delivery, offering unique solutions to overcome the challenges posed by traditional therapeutic methods. This article ...

Researchers at the Terasaki Institute for Biomedical Innovation have developed a novel nanoparticle-based therapy for obesity ...

According to a recent study published in ACS Nano, researchers at the Terasaki Institute for Biomedical Innovation have ...

In this Thought Leader article., Ian Johnston from Cytiva discusses challenges related to process development, scaling technology, regulatory approvals, and GMP guidelines.

Editas Medicine announced proof-of-concept data for a gene-editing approach for sickle cell disease that doesn't need a stem ...

Tumors often contain areas of oxygen-deficient tissue that frequently withstand conventional therapies. This is because the ...

CRISPR/Cas9 is a gene editing tool that has revolutionized biomedical research and led to the first FDA-approved CRISPR-based gene therapy.

In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on Prime Medicine, Inc. (PRME – Research Report), with a ...

Researchers at the Terasaki Institute for Biomedical Innovation have developed a novel nanoparticle-based therapy for obesity treatment, as reported in a recent study published in ACS Nano. The ...

Researchers at Michigan State University in East Lansing have tested a new nanoparticle nanotherapy infusion that precisely targets inflammation and activates the immune system to help clear out ...